Review Articles Concerning Pulmonary Vascular Disease

Thiamine: An indispensable regulator of paediatric neuro-cardiovascular health and diseases

Ysphaneendramallimoggala, Monalisa Biswas, Stanly Elstin Anburaj, Faiza Iqbal. Shrikiran, Varashree Bolar Suryakanth Leslie Edward S. LewisKasturba Medical College and Manipal Academy of Higher Education. India European Journal of PediatricsEur J Pediatr 2024; DOI: 10.1007/s00431-024-05756-4 AbstractThe sustainable developmental goals emphasize good health, reduction in preventable neonatal and under-five mortalities, and attaining zero hunger. However, South Asian countries […]

Thiamine: An indispensable regulator of paediatric neuro-cardiovascular health and diseases Read More »

Hereditary hemorrhagic telangiectasia – pediatric review

Ionela Iacobas, Adrienne M. HammillTexas Children’s Hospital and Baylor College of Medicine. Cincinnati Children’s Hospital Medical Center.United States Current Opinion in PediatricsCurr Opin Pediatr 2024; DOI: 10.1097/MOP.0000000000001398 AbstractPurpose of review: Hereditary hemorrhagic telangiectasia (HHT) diagnostic and management approach for pediatrics underwent significant advances over the last couple of years.Recent findings: In 2020, new guidelines for HHT were published

Hereditary hemorrhagic telangiectasia – pediatric review Read More »

Caesarean section and respiratory system disorders in newborns

Maryam Yeganegi, Nazanin Hajizadeh, Reza Bahrami, Sepideh Azizi, Seyed Reza Mirjalili, Zahra Marzbanrad, Maryam Saeida-Ardekani Mohamad Hosein Lookzadeh, Kamran Alijanpour, Maryam Aghasipour Mohammad Golshan-Tafti, Mahmood Noorishadkam, Hossein NeamatzadehIranshahr University of Medical Sciences. Shiraz University of Medical Sciences. Iran University of Medical Sciences. Firoozgar Hospital. Imam Hossein Hospital and Shahid Beheshti University of Medical Sciences. Shahid

Caesarean section and respiratory system disorders in newborns Read More »

Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application

Deshuang Zhang, Zhixian Gou, Yi Qu, Xiaojuan SuWest China Second University Hospital and Sichuan University. School of Clinical Medicine and First Affiliated Hospital of Chengdu Medical College. China Biomedicine and PharmacotherapyBiomed Pharmacother 2024; DOI: 10.1016/j.biopha.2024.117421 AbstractLung diseases have complex pathogenesis and treatment challenges, showing an obvious increase in the rate of diagnosis and death every year.

Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application Read More »

Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors

Herlina Dimiati Dimas Arya Umara, Iflan NaufalUniversitas Syiah Kuala,Indonesia F1000 ResearchF1000Res 2022; DOI: 10.12688/f1000research.53966.2 AbstractRespiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first occurred in Wuhan, China, in December 2019 and was declared as a pandemic by WHO. The interaction between the 2019 coronavirus disease (COVID-19) and pulmonary hypertension (PH) in children

Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors Read More »

Embracing the challenges of neonatal and paediatric pulmonary hypertension

Dunbar Ivy, Erika B. Rosenzweig, Steven H. Abman, Maurice Beghetti, Damien Bonnet, Johannes Menno Douwes, Alessandra Manes, RolfM.F.BergerUniversity of Colorado School of Medicine and Children’s Hospital Colorado. Maria Fareri Children’s Hospital at WMC Health and New York Medical College of Touro University. Geneva University Hospital and University of Geneva. Necker Hospital for Sick Children. Beatrix

Embracing the challenges of neonatal and paediatric pulmonary hypertension Read More »

Genetics and precision genomics approaches to pulmonary hypertension

Eric D. Austin, Micheala A. Aldred, Mona Alotaibi, Stefan Gräf, William C. Nichols, Richard C. Trembath, Wendy K. ChungVanderbilt University Medical Center. Indiana University School of Medicine. University of California San Diego. University of Cambridge. Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine. King’s College London. Boston Children’s Hospital. United States

Genetics and precision genomics approaches to pulmonary hypertension Read More »

Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension

Pramod Pharande, Arvind Sehgal, Samuel MenahemMonash Children’s Hospital, Monash Medical Centre and Monash University. University of Melbourne.Australia Journal of Cardiovascular Development and DiseaseJ Cardiovasc Dev Dis 2024; 11: DOI: 10.3390/jcdd11080233 AbstractBronchopulmonary dysplasia (BPD) remains the most common respiratory disorder of prematurity for infants born before 32 weeks of gestational age (GA). Early and prolonged exposure to

Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension Read More »

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery

Heidi M. Manour, Priya Muralidharan, Don Hayes Jr.University of Arizona. Ohio State University College of Medicine. United States Journal of Aerosol Medicine and Pulmonary Drug DeliveryJ Aerosol Med Pulm Drug Deliv 2024; 37: 202-218 DOI: 10.1089/jamp.2024.29117.mk AbstractAn increasing growth in nanotechnology is evident from the growing number of products approved in the past decade. Nanotechnology can

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery Read More »

The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?

Julie Wacker, Raphael Joye, Leon Genecand, Frederic Lador, Maurice BeghettiUniversity Hospitals of Geneva. Switzerland Expert Review of Clinical PharmacologyExpert Rev Clin Pharmacol 2024; DOI: 10.1080/17512433.2024.2396119 AbstractIntroduction: Pediatric pulmonary hypertension is a rare condition. Survival remains poor in the current management era. There is a lack of data regarding the medical management of pediatric pulmonary hypertension and most

The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met? Read More »

Scroll to Top